Skip to Main Content
BLACK FRIDAY SALE

60% off Quiver Premium for new subscribers

...

Use Promo Code:

BLACKFRIDAY26

Novo-Nordisk A/S

NVO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of NVO by members of U.S. Congress

Politician Type Traded
Kevin Hern House / R Sale $1,001 - $15,000 Sep 10, 2026
Kevin Hern House / R Sale $1,001 - $15,000 Aug 31, 2026
Scott Franklin House / R Purchase $1,001 - $15,000 Aug 26, 2026
Alan Armstrong Senate / R Purchase $15,001 - $50,000 Mar 30, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 13, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 13, 2026
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Oct 15, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Sep 11, 2025
Marjorie Taylor Greene House / R Purchase $1,001 - $15,000 Aug 28, 2025
Marjorie Taylor Greene House / R Purchase $15,001 - $50,000 Aug 19, 2025
Scott Franklin House / R Purchase $1,001 - $15,000 Aug 04, 2025
Scott Franklin House / R Purchase $15,001 - $50,000 Aug 04, 2025
Scott Franklin House / R Purchase $1,001 - $15,000 Aug 04, 2025
Scott Franklin House / R Purchase $1,001 - $15,000 Aug 04, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Aug 04, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Jul 30, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Jul 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Jul 10, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Jun 27, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Jun 16, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 09, 2025
Laurel M. Lee House / R Sale $1,001 - $15,000 May 08, 2025
Scott Franklin House / R Purchase $1,001 - $15,000 Mar 27, 2025
Scott Franklin House / R Purchase $15,001 - $50,000 Mar 27, 2025
Byron Donalds House / R Sale $1,001 - $15,000 Mar 20, 2025
Byron Donalds House / R Sale $1,001 - $15,000 Mar 20, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Nov 19, 2024
Michael T. McCaul House / R Sale $50,001 - $100,000 Nov 19, 2024
Byron Donalds House / R Sale $1,001 - $15,000 N/A
Val T. Hoyle House / D Purchase $1,001 - $15,000 Oct 29, 2024
Michael T. McCaul House / R Sale $1,001 - $15,000 N/A
John James House / R Sale $1,001 - $15,000 Sep 04, 2024
Michael T. McCaul House / R Sale $1,001 - $15,000 Aug 26, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 Aug 09, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 Aug 09, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Jul 12, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 N/A
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 29, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 29, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 28, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 06, 2024
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 06, 2024
Michael T. McCaul House / R Purchase $50,001 - $100,000 Apr 24, 2024
Michael T. McCaul House / R Purchase $50,001 - $100,000 Apr 24, 2024
Michael T. McCaul House / R Purchase $50,001 - $100,000 Apr 23, 2024
Michael T. McCaul House / R Purchase $100,001 - $250,000 Apr 23, 2024
Ro Khanna House / D Sale $1,001 - $15,000 Feb 09, 2024
NVO Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
NVO Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
NVO Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in NVO holdings by institutional investors

Quarterly net insider trading by NVO's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

  • $2,010,000 Oct 20, 2026 Issue: Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills) Health Issues Budget/Appropriations
  • $1,300,000 Jul 20, 2026 Issue: Health Issues Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills)
  • $1,290,000 Apr 20, 2026 Issue: Health Issues Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills)
  • $2,120,000 Jan 20, 2026 Issue: Health Issues Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills)
  • $1,730,000 Oct 20, 2025 Issue: Health Issues Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills)
  • $1,050,000 Jul 16, 2025 Issue: Health Issues Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark Taxation/Internal Revenue Code Tariff (miscellaneous tariff bills)
  • $2,330,000 Apr 18, 2025 Issue: Health Issues Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark
  • $1,240,000 Jan 17, 2025 Issue: Health Issues Budget/Appropriations Medicare/Medicaid Copyright/Patent/Trademark
  • $780,000 Oct 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
  • $1,060,000 Jul 19, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
  • $1,490,000 Apr 18, 2024 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues
  • $60,000 Feb 07, 2024 Issue: Budget/Appropriations Pharmacy Medicare/Medicaid Health Issues
  • $600,000 Oct 19, 2023 Issue: Copyright/Patent/Trademark Medicare/Medicaid Budget/Appropriations Health Issues

Former government officials who have lobbied for NVO

106 former government officials from 65 congressional offices at 21 lobbying firms have lobbied for NVO, most recently Oct 20, 2026.

  • Michael A. Arcuri
    Christopher Wilcox House LA, Leg Counsel, LD & Counsel, Rep. Arcuri; LD & Counsel, Rep. Demings Formerly with Michael A. Arcuri · WILLIAMS AND JENSEN, PLLC · Oct 20, 2026
  • Chuck Grassley
    Jeanne Haggerty Senate Legislative Correspondent Senator Chuck Grassley and Senate Aging Committee (shared staff), Legislative Aide Senate Finance Committee, Health Policy Coordinator Health Subcommittee Energy and Commerce, Professional Staff Member Formerly with Chuck Grassley · WILLIAMS AND JENSEN, PLLC · Oct 20, 2026
  • Bill Cassidy
    Robert Butora Senate Health Policy Advisor, Senator Bill Cassidy; Senior Health Policy Advisor, Representative Leonard Lance, Health Legislative Assistant, Representative Michael Burgess Formerly with Bill Cassidy · WILLIAMS AND JENSEN, PLLC · Oct 20, 2026
  • Raissa Downs Senate Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte. Formerly HELP Cmte. · TARPLIN, DOWNS & YOUNG, LLC · Oct 20, 2026
  • Jennifer Young Congress Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance Formerly Cmte. on Finance · TARPLIN, DOWNS & YOUNG, LLC · Oct 20, 2026
  • Tom Harkin
    Pamela Smith Senate Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun Formerly with Tom Harkin · TARPLIN, DOWNS & YOUNG, LLC · Oct 20, 2026
  • Emily Murry House Staff Dir., Sub. Cmte. on Health, W&M Cmte; Sr. Policy Advisor, Majority Leader McCarthy; Policy Advisor, Majority Whip McCarthy; Professional Staff, Republican Study Cmte.; Leg. Aid, Rep. Ken Calvert; Leg. Asst., Rep. Tom Price Formerly Ken Calvert · TARPLIN, DOWNS & YOUNG, LLC · Oct 20, 2026
  • Peter Fise Congress Health Counsel for Sen. Cmte on Finance, Health Counsel for Sen. Jeanne Shaheen, Staff Assistant for House Cmte on Oversight & Government Reform Formerly Cmte on Finance · TARPLIN, DOWNS & YOUNG, LLC · Oct 20, 2026
See all 106 on the Revolving Door dashboard

NVO Estimated quarterly lobbying spending

NVO Revenue by Segment or Geography

By Segment
By Geography
NVO Income Statement
NVO Balance Sheet
NVO Cash Flow
U.S. Patents

New NVO patent grants

  • Patent Title: Antibodies that are capable of specifically binding tissue factor pathway inhibitor Jan. 05, 2016
  • Patent Title: Remodeling and glycopegylation of fibroblast growth factor (fgf) Dec. 01, 2015
  • Patent Title: Injection device with mode locking means Nov. 24, 2015
  • Patent Title: Low friction systems and devices Nov. 17, 2015
  • Patent Title: Human insulin analogues and derivatives comprising cysteine substitutions Nov. 17, 2015
  • Patent Title: Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants Nov. 17, 2015
  • Patent Title: Glycosylation of peptides via o-linked glycosylation sequences Nov. 17, 2015
  • Patent Title: Electronically assisted drug delivery device Nov. 17, 2015
  • Patent Title: Secure pairing of electronic devices using dual means of communication Nov. 03, 2015
  • Patent Title: Conjugated factor viii molecules Oct. 06, 2015
  • Patent Title: Insulin analogues with an acyl and alkylene glycol moiety Oct. 06, 2015
  • Patent Title: Magnetic time delay indicator and an injection device incorporating such Sep. 29, 2015
  • Patent Title: Shieldable needle assembly with biased safety shield Sep. 22, 2015
  • Patent Title: Dial-down mechanism for wind-up pen Sep. 15, 2015
  • Patent Title: Antibodies against human nkg2d and uses thereof Sep. 08, 2015
  • Patent Title: Compounds suitable for treatment of haemophilia Sep. 08, 2015
  • Patent Title: Back needle Sep. 08, 2015
  • Patent Title: Process for preparing fgf21 with low degree of o-glycosylation Sep. 01, 2015
  • Patent Title: Auto-priming injection device Aug. 25, 2015
  • Patent Title: Injection device with visual end-of-content indication Aug. 25, 2015
  • Patent Title: Medical device with value sensor Aug. 18, 2015
  • Patent Title: Automatic injection device with a top release mechanism Aug. 18, 2015
  • Patent Title: Electronic module for mechanical medication delivery devices Aug. 11, 2015
  • Patent Title: Dose setting mechanism for an injection device capable of presetting a maximum dose Aug. 11, 2015
  • Patent Title: Piston rod foot Aug. 11, 2015
  • Patent Title: Peptidyl α-hydroxyglycine α-amidating lyases Aug. 04, 2015
  • Patent Title: Disposable double point injection needle and an insulin injection system comprising a disposable double point injection needle Aug. 04, 2015
  • Patent Title: Medical assembly with monitoring device Jul. 28, 2015
  • Patent Title: Selective pyy compounds and uses thereof Jul. 21, 2015
  • Patent Title: Peptides derivatized with a-b-c-d- and their therapeutical use Jun. 30, 2015
  • Patent Title: Medical container protected against cracking Jun. 30, 2015
  • Patent Title: Therapeutic factor viii antibodies Jun. 23, 2015
  • Patent Title: Polypeptide protracting tags Jun. 23, 2015
  • Patent Title: Method for making mature insulin polypeptides Jun. 16, 2015
  • Patent Title: Medical delivery system with a rotatable coding element Jun. 09, 2015
  • Patent Title: Protease stabilized, acylated insulin analogues Jun. 02, 2015
  • Patent Title: Medical delivery device having air shot means Jun. 02, 2015
  • Patent Title: Long-acting gastrin derivatives May. 26, 2015
  • Patent Title: Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids May. 19, 2015
  • Patent Title: Pharmaceutical formulations comprising an insulin derivative May. 19, 2015
  • Patent Title: Glycopegylated granulocyte colony stimulating factor May. 12, 2015
  • Patent Title: Amylin analogues and pharmaceutical compositions thereof May. 12, 2015
  • Patent Title: Amylin analogs and pharmaceutical compositions thereof May. 05, 2015
  • Patent Title: Injection device May. 05, 2015
  • Patent Title: Conjugated fviii variants Apr. 28, 2015
  • Patent Title: Protease resistant insulin analogues Apr. 28, 2015
  • Patent Title: Medical injection device Apr. 28, 2015
  • Patent Title: Two-part hinged needle magazine Apr. 28, 2015
  • Patent Title: Acylated exendin-4 compounds Apr. 21, 2015
  • Patent Title: Determination of position of injection needle Apr. 14, 2015
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to NVO from public contracts

NVO News

Recent insights relating to NVO

Political Exposure

Pending bills that may affect NVO

Bill
Impact
Confidence
Date
CNBC Recommendations

Recent picks made for NVO stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NVO

NVO Analyst Ratings

NVO Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
NVO Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $NVO stock a Buy, Sell, or Hold?

  • What is the price target for $NVO stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

NVO Top Shareholders
Shareholder
Shares Held
NVO Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $NVO stock?

  • Who owns the most shares of $NVO stock?

  • What funds own $NVO stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

NVO Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view NVO Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About NVO

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the world's leading provider of diabetes care products. Based in Denmark, the company manufactures and markets a variety of human and modern insulins for patients with diabetes, as well as injectable and oral GLP-1 therapies, across its obesity and diabetes care segment. Novo also has a rare disease segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo-Nordisk A/S (NVO) Historical Stock Prices

Novo-Nordisk A/S (NVO) closed at $38.87 on November 19, 2026. Over the past year its adjusted close ranged from $34.34 to $60.96. Daily prices go back to January 2, 2014, 3,241 trading days in all.

  • 1 month-1.22%
  • 3 months-15.76%
  • Year to date-19.82%
  • 1 year-16.75%
  • 3 years-59.12%
  • 5 years-23.53%
  • Max+178.66%
See every congressional and insider trade on the NVO price chart

Quiver Premium charts NVO's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Nov 19, 2026 39.35 39.81 38.61 38.87 38.87 17,613,666
Nov 18, 2026 40.13 40.57 39.32 39.43 39.43 16,559,925
Nov 17, 2026 40.72 40.96 40.23 40.70 40.70 17,838,963
Nov 16, 2026 42.05 42.30 41.44 41.60 41.60 16,658,080
Nov 13, 2026 40.97 41.80 40.64 41.63 41.63 11,714,401
Nov 12, 2026 40.93 41.01 40.08 40.65 40.65 15,749,512
Nov 11, 2026 40.50 41.20 40.09 41.09 41.09 11,707,411
Nov 10, 2026 40.71 40.81 40.38 40.70 40.70 6,530,886
Nov 9, 2026 41.13 41.63 40.55 41.38 41.38 11,761,217
Nov 6, 2026 39.76 40.55 39.53 40.31 40.31 9,236,759
Nov 5, 2026 41.16 41.17 39.99 40.30 40.30 18,499,392
Nov 4, 2026 42.45 43.24 42.12 42.18 42.18 26,038,262
Nov 3, 2026 40.34 40.63 39.96 40.19 40.19 12,216,047
Nov 2, 2026 40.10 40.78 40.06 40.45 40.45 11,184,322
Oct 30, 2026 39.61 40.10 39.54 40.00 40.00 15,277,510
Oct 29, 2026 38.67 39.22 38.56 39.14 39.14 10,441,293
Oct 28, 2026 38.11 38.54 37.96 38.29 38.29 11,358,981
Oct 27, 2026 38.58 39.02 38.54 38.67 38.67 6,775,935
Oct 26, 2026 39.02 39.23 38.67 39.13 39.13 8,041,530
Oct 23, 2026 39.21 39.29 38.75 39.05 39.05 9,188,277
Oct 22, 2026 39.39 39.77 39.24 39.43 39.43 8,560,714
Oct 21, 2026 39.25 39.49 39.05 39.06 39.06 6,802,805
Oct 20, 2026 38.91 39.38 38.81 39.35 39.35 9,412,618
Oct 19, 2026 38.65 38.84 38.35 38.42 38.42 7,452,550
Oct 16, 2026 39.33 39.40 38.67 38.83 38.83 10,823,139
Oct 15, 2026 38.99 39.68 38.89 39.22 39.22 14,775,007
Oct 14, 2026 37.91 38.42 37.90 38.12 38.12 9,363,628
Oct 13, 2026 38.74 38.89 37.98 38.06 38.06 9,261,609
Oct 12, 2026 38.85 38.85 38.26 38.58 38.58 8,722,170
Oct 9, 2026 38.11 38.68 38.06 38.64 38.64 9,645,389
Oct 8, 2026 37.80 38.23 37.51 38.18 38.18 11,817,177
Oct 7, 2026 37.57 38.47 37.51 38.26 38.26 13,665,078
Oct 6, 2026 37.35 37.53 36.84 37.53 37.53 13,696,527
Oct 5, 2026 36.94 37.61 36.85 37.54 37.54 18,700,717
Oct 2, 2026 37.63 37.65 37.17 37.32 37.32 10,261,230
Oct 1, 2026 37.80 37.97 37.37 37.40 37.40 12,656,899
Sep 30, 2026 38.05 38.77 37.88 37.91 37.91 21,556,020
Sep 29, 2026 38.21 38.38 38.05 38.31 38.31 9,403,505
Sep 28, 2026 38.40 38.90 38.23 38.71 38.71 11,428,804
Sep 25, 2026 38.81 38.83 38.41 38.80 38.80 10,061,950
Sep 24, 2026 37.95 38.72 37.92 38.62 38.62 20,064,204
Sep 23, 2026 38.90 39.14 38.16 38.17 38.17 18,439,042
Sep 22, 2026 39.50 39.89 39.10 39.40 39.40 24,462,879
Sep 21, 2026 41.05 41.17 39.54 39.80 39.80 49,339,314
Sep 18, 2026 43.50 43.54 42.78 43.24 43.24 10,370,709
Sep 17, 2026 41.98 43.44 41.96 43.19 43.19 12,947,146
Sep 16, 2026 42.47 42.72 41.47 41.71 41.71 11,669,847
Sep 15, 2026 42.73 43.00 42.40 42.53 42.53 8,862,135
Sep 14, 2026 43.66 43.71 43.07 43.45 43.45 6,564,589
Sep 11, 2026 43.20 43.50 42.72 43.07 43.07 11,029,063
Sep 10, 2026 44.60 44.82 44.01 44.01 44.01 6,580,888
Sep 9, 2026 45.00 45.40 44.52 44.56 44.56 8,833,554
Sep 8, 2026 45.58 45.91 45.15 45.16 45.16 10,353,971
Sep 4, 2026 46.35 46.74 46.04 46.60 46.60 6,219,243
Sep 3, 2026 47.99 48.00 46.56 47.51 47.51 8,769,639
Sep 2, 2026 46.05 47.01 45.91 46.77 46.77 13,602,634
Sep 1, 2026 45.80 46.16 45.06 45.12 45.12 9,355,998
Aug 31, 2026 45.28 45.61 44.95 45.33 45.33 7,607,222
Aug 28, 2026 46.17 46.21 45.41 45.61 45.61 8,504,974
Aug 27, 2026 45.97 46.33 45.70 46.26 46.26 13,024,424
Aug 26, 2026 47.80 48.04 46.87 47.19 47.19 8,877,891
Aug 25, 2026 47.84 48.66 47.56 48.66 48.66 15,526,741
Aug 24, 2026 47.09 47.30 46.56 46.92 46.92 9,674,151
Aug 21, 2026 46.35 47.16 46.34 46.74 46.74 10,912,622
Aug 20, 2026 46.89 46.90 46.11 46.14 46.14 9,669,896
Aug 19, 2026 46.01 47.20 45.84 46.48 46.48 19,511,352
Aug 18, 2026 44.91 46.06 44.76 45.71 45.71 12,089,921
Aug 17, 2026$0.5786 dividend 45.18 45.45 44.68 44.88 44.88 14,626,376
Aug 14, 2026 46.90 47.05 45.75 45.89 45.31 10,853,740
Aug 13, 2026 45.96 46.78 45.73 46.72 46.12 10,186,917
Aug 12, 2026 45.87 46.55 45.56 46.39 45.80 9,563,767
Aug 11, 2026 47.45 47.67 46.93 47.17 46.57 7,834,671
Aug 10, 2026 47.00 47.73 46.66 47.73 47.12 10,185,208
Aug 7, 2026 47.15 47.50 46.73 47.26 46.66 12,079,424
Aug 6, 2026 45.61 45.98 44.93 45.97 45.38 13,121,023
Aug 5, 2026 44.81 45.72 44.38 44.53 43.96 22,275,739
Aug 4, 2026 47.59 49.15 43.68 44.28 43.72 47,478,812
Aug 3, 2026 47.00 47.20 46.19 47.09 46.49 11,859,717
Jul 31, 2026 47.40 47.59 46.44 47.08 46.48 26,798,041
Jul 30, 2026 50.71 51.62 50.51 51.61 50.95 10,601,708
Jul 29, 2026 51.00 52.12 50.92 51.58 50.92 8,712,967
Jul 28, 2026 49.95 51.23 49.95 50.96 50.31 9,521,673
Jul 27, 2026 49.17 49.96 48.82 49.67 49.04 6,806,081
Jul 24, 2026 48.83 49.52 48.70 48.77 48.15 10,799,111
Jul 23, 2026 48.38 48.93 48.11 48.18 47.57 8,178,174
Jul 22, 2026 49.45 49.54 47.98 48.19 47.58 8,289,438
Jul 21, 2026 49.34 49.84 48.95 49.38 48.75 5,785,783
Jul 20, 2026 50.45 50.50 49.56 49.61 48.98 7,298,991
Jul 17, 2026 51.06 51.40 50.00 50.32 49.68 9,542,554
Jul 16, 2026 50.91 51.77 50.60 51.48 50.83 9,792,355
Jul 15, 2026 49.36 51.00 49.36 50.56 49.92 10,314,858
Jul 14, 2026 48.77 49.27 48.29 49.07 48.45 6,623,656
Jul 13, 2026 49.17 49.67 48.76 49.28 48.65 7,420,426
Jul 10, 2026 49.17 49.64 48.73 49.48 48.85 6,317,822
Jul 9, 2026 48.69 49.38 48.58 48.88 48.26 5,458,468
Jul 8, 2026 48.75 49.47 48.50 48.89 48.27 9,137,799
Jul 7, 2026 50.29 50.44 49.30 49.64 49.01 12,222,735
Jul 6, 2026 49.27 49.48 48.55 49.26 48.63 12,333,311
Jul 2, 2026 49.82 50.90 49.78 50.43 49.79 12,080,179
Jul 1, 2026 49.02 49.55 48.61 48.77 48.15 11,248,361
Jun 30, 2026 48.51 48.62 47.87 47.94 47.33 8,579,329
Jun 29, 2026 47.72 48.48 47.61 48.34 47.73 9,324,109
Jun 26, 2026 47.12 48.50 46.99 48.07 47.46 20,136,350
Jun 25, 2026 47.81 48.24 47.32 47.64 47.03 12,495,802
Jun 24, 2026 47.10 47.65 47.02 47.41 46.81 15,078,197
Jun 23, 2026 46.80 47.43 46.44 47.42 46.82 17,674,250
Jun 22, 2026 44.01 46.45 43.90 45.88 45.30 17,141,297
Jun 18, 2026 43.45 44.00 42.52 43.19 42.64 8,996,732
Jun 17, 2026 44.97 45.00 43.46 43.52 42.97 9,862,778
Jun 16, 2026 44.03 44.11 43.36 43.55 43.00 7,146,608
Jun 15, 2026 44.69 44.79 43.81 43.92 43.36 10,223,347
Jun 12, 2026 43.94 44.59 43.72 43.88 43.32 14,799,174
Jun 11, 2026 42.97 44.11 42.94 43.96 43.40 12,719,843
Jun 10, 2026 41.67 44.03 41.66 42.81 42.27 16,563,859
Jun 9, 2026 41.08 42.31 41.08 42.19 41.65 14,720,100
Jun 8, 2026 42.22 42.41 41.00 41.02 40.50 20,690,221
Jun 5, 2026 44.05 44.22 42.85 42.96 42.41 10,855,623
Jun 4, 2026 43.09 44.37 42.22 43.75 43.19 16,440,291
Jun 3, 2026 42.72 42.77 41.90 42.00 41.47 11,341,964
Jun 2, 2026 43.48 43.63 42.25 42.92 42.37 17,145,222
Jun 1, 2026 45.39 45.39 43.79 44.07 43.51 12,978,865
May 29, 2026 45.48 45.89 45.15 45.58 45.00 10,986,402
May 28, 2026 44.05 46.05 43.95 45.51 44.93 14,639,281
May 27, 2026 44.18 45.23 44.17 44.55 43.98 11,335,410
May 26, 2026 44.74 44.99 44.17 44.19 43.63 9,355,690
May 22, 2026 44.61 45.18 44.47 44.96 44.39 10,790,951
May 21, 2026 44.22 44.59 43.73 44.39 43.83 11,627,958
May 20, 2026 44.69 45.25 44.43 45.07 44.50 10,762,170
May 19, 2026 44.36 44.84 44.08 44.28 43.72 9,704,429
May 18, 2026 44.63 45.09 43.97 44.28 43.72 15,403,401
May 15, 2026 45.40 45.50 44.25 44.74 44.17 16,383,758
May 14, 2026 46.79 46.84 45.54 45.80 45.22 13,297,231
May 13, 2026 47.07 47.21 46.65 47.08 46.48 9,998,736
May 12, 2026 46.99 47.11 46.29 47.00 46.40 14,248,176
May 11, 2026 46.69 47.79 46.27 46.40 45.81 17,851,623
May 8, 2026 45.97 46.14 45.19 46.07 45.48 12,054,050
May 7, 2026 46.55 47.08 45.75 45.80 45.22 16,912,603
May 6, 2026 46.31 47.55 45.53 45.76 45.18 30,894,991
May 5, 2026 44.52 45.12 44.21 44.87 44.30 21,291,969
May 4, 2026 44.15 44.58 43.84 44.39 43.83 18,675,668
May 1, 2026 43.31 44.04 43.09 43.88 43.32 26,254,487
Apr 30, 2026 41.85 42.85 41.65 42.22 41.68 25,208,115
Apr 29, 2026 40.76 40.78 39.70 40.29 39.78 16,339,354
Apr 28, 2026 41.30 42.08 41.10 41.17 40.65 16,387,749
Apr 27, 2026 40.76 41.67 40.55 41.20 40.68 19,367,656
Apr 24, 2026 40.06 41.23 39.89 41.17 40.65 25,017,314
Apr 23, 2026 39.13 39.20 38.02 38.52 38.03 12,266,488
Apr 22, 2026 39.15 39.33 38.85 39.15 38.65 17,620,577
Apr 21, 2026 40.13 40.20 38.70 39.42 38.92 25,186,415
Apr 20, 2026 40.51 40.85 40.26 40.46 39.95 10,467,085
Apr 17, 2026 40.98 41.28 40.43 40.52 40.00 13,204,007
Apr 16, 2026 41.26 41.41 40.23 40.93 40.41 16,083,752
Apr 15, 2026 39.79 40.86 39.67 40.81 40.29 19,479,402
Apr 14, 2026 39.13 39.41 38.73 39.32 38.82 19,729,298
Apr 13, 2026 37.13 38.01 36.95 37.98 37.50 12,692,219
Apr 10, 2026 38.30 38.42 37.42 37.52 37.04 11,400,467
Apr 9, 2026 37.18 37.65 36.82 37.44 36.96 11,231,668
Apr 8, 2026 38.03 38.19 37.33 37.61 37.13 13,882,468
Apr 7, 2026 36.40 37.03 35.97 36.91 36.44 13,916,313
Apr 6, 2026 37.00 37.42 36.52 36.67 36.20 11,535,481
Apr 2, 2026 36.09 36.98 35.62 36.98 36.51 14,695,847
Apr 1, 2026 36.77 37.09 35.78 36.48 36.02 24,090,602
Mar 31, 2026 35.41 36.75 35.32 36.75 36.28 18,979,196
Mar 30, 2026$1.275 dividend 35.13 35.63 35.12 35.29 34.84 17,393,764
Mar 27, 2026 36.31 36.49 35.89 36.04 34.34 14,694,581
Mar 26, 2026 36.29 37.44 36.13 36.40 34.68 20,602,819
Mar 25, 2026 37.15 37.39 36.23 36.33 34.62 16,442,749
Mar 24, 2026 36.85 37.20 36.55 36.89 35.15 16,143,252
Mar 23, 2026 36.83 37.21 36.48 36.82 35.08 15,011,789
Mar 20, 2026 36.49 37.00 36.17 36.53 34.81 26,367,715
Mar 19, 2026 36.36 37.25 36.36 37.08 35.33 21,364,548
Mar 18, 2026 37.44 37.69 37.00 37.45 35.68 26,115,941
Mar 17, 2026 38.67 39.27 38.38 38.43 36.62 12,174,878
Mar 16, 2026 37.97 38.59 37.79 38.58 36.76 11,442,723
Mar 13, 2026 38.39 38.80 37.70 37.96 36.17 11,608,569
Mar 12, 2026 38.68 39.02 37.85 38.02 36.23 17,123,044
Mar 11, 2026 38.73 38.99 38.52 38.83 37.00 13,208,243
Mar 10, 2026 39.19 39.22 38.18 38.72 36.89 20,832,631
Mar 9, 2026 39.19 39.88 38.49 39.78 37.90 23,795,968
Mar 6, 2026 38.58 38.85 38.16 38.58 36.76 15,632,401
Mar 5, 2026 38.28 39.12 38.08 39.07 37.23 21,578,977
Mar 4, 2026 37.63 38.60 37.29 38.50 36.69 26,808,135
Mar 3, 2026 36.37 36.95 35.85 36.66 34.93 34,247,828
Mar 2, 2026 36.83 37.84 36.72 37.76 35.98 22,094,234
Feb 27, 2026 37.54 37.86 37.33 37.45 35.68 24,222,691
Feb 26, 2026 37.83 38.07 37.31 37.62 35.85 35,499,018
Feb 25, 2026 37.70 38.24 37.65 38.16 36.36 55,460,046
Feb 24, 2026 38.50 39.07 38.36 38.59 36.77 43,931,660
Feb 23, 2026 40.19 41.09 39.34 39.63 37.76 98,664,012
Feb 20, 2026 47.69 47.75 47.03 47.42 45.18 12,285,848
Feb 19, 2026 48.72 48.77 48.18 48.45 46.16 8,289,430
Feb 18, 2026 48.84 49.35 48.63 49.23 46.91 11,296,409
Feb 17, 2026 49.11 49.85 48.67 49.37 47.04 9,892,746
Feb 13, 2026 49.30 49.84 49.20 49.57 47.23 10,156,106
Feb 12, 2026 48.84 50.07 48.12 48.93 46.62 11,708,506
Feb 11, 2026 48.73 48.96 48.08 48.74 46.44 12,245,039
Feb 10, 2026 50.02 50.46 48.98 49.12 46.80 15,847,932
Feb 9, 2026 50.13 51.09 49.01 49.37 47.04 30,096,850
Feb 6, 2026 46.37 47.74 45.84 47.64 45.39 36,856,625
Feb 5, 2026 45.05 45.67 43.24 43.34 41.30 54,446,133
Feb 4, 2026 47.95 49.10 46.47 47.19 44.97 46,859,689
Feb 3, 2026 58.35 58.63 49.96 50.30 47.93 69,933,216
Feb 2, 2026 57.91 59.30 57.79 58.93 56.15 16,647,875
Jan 30, 2026 59.27 59.91 58.59 59.43 56.63 12,085,775
Jan 29, 2026 59.93 59.93 58.80 59.33 56.53 15,841,871
Jan 28, 2026 61.48 61.56 59.99 60.33 57.48 16,235,907
Jan 27, 2026 62.89 63.49 62.49 62.89 59.92 13,426,491
Jan 26, 2026 62.88 63.99 62.67 63.98 60.96 20,107,952
Jan 23, 2026 63.40 64.16 62.02 62.26 59.32 28,013,371
Jan 22, 2026 61.44 62.44 61.04 62.23 59.30 20,301,975
Jan 21, 2026 60.01 60.17 57.56 59.32 56.52 30,601,938
Jan 20, 2026 60.22 62.17 59.95 60.68 57.82 30,424,630
Jan 16, 2026 59.91 62.40 59.24 62.33 59.39 43,376,971
Jan 15, 2026 57.79 57.84 56.29 57.12 54.43 25,752,330
Jan 14, 2026 58.84 59.75 58.34 58.91 56.13 16,344,057
Jan 13, 2026 60.58 60.63 59.14 59.64 56.83 16,912,890
Jan 12, 2026 60.14 60.30 59.10 59.86 57.04 19,311,543
Jan 9, 2026 59.47 60.64 58.78 58.81 56.04 29,064,402
Jan 8, 2026 57.04 57.91 57.01 57.34 54.64 17,505,646
Jan 7, 2026 56.85 57.77 56.23 56.57 53.90 17,538,435
Jan 6, 2026 57.18 58.15 56.02 56.26 53.61 32,942,190
Jan 5, 2026 53.92 55.41 53.36 55.11 52.51 30,028,729
Jan 2, 2026 51.61 52.41 51.41 52.39 49.92 12,134,109
Dec 31, 2025 51.05 51.26 50.55 50.88 48.48 10,803,856
Dec 30, 2025 51.52 51.67 51.06 51.22 48.80 11,902,520
Dec 29, 2025 51.56 51.99 51.34 51.47 49.04 16,895,918
Dec 26, 2025 53.02 53.02 51.70 52.40 49.93 13,255,553
Dec 24, 2025 52.85 53.63 52.00 52.56 50.08 19,300,102
Dec 23, 2025 52.67 53.20 51.04 51.61 49.18 67,564,823
Dec 22, 2025 47.75 48.22 47.59 48.10 45.83 16,059,128
Dec 19, 2025 48.10 48.80 47.98 48.09 45.82 10,927,109
Dec 18, 2025 48.00 48.31 47.52 47.61 45.37 8,303,277
Dec 17, 2025 48.10 48.75 47.73 47.77 45.52 10,340,893
Dec 16, 2025 49.81 49.97 48.41 48.96 46.65 14,148,517
Dec 15, 2025 49.96 50.66 49.55 50.37 47.99 11,354,710
Dec 12, 2025 50.53 50.75 49.91 50.18 47.81 12,392,841
Dec 11, 2025 49.96 50.54 49.59 50.29 47.92 15,601,182
Dec 10, 2025 47.40 49.50 47.04 49.05 46.74 16,964,840
Dec 9, 2025 46.22 46.79 46.08 46.36 44.17 10,247,881
Dec 8, 2025 47.16 47.17 46.35 46.77 44.56 14,872,530
Dec 5, 2025 48.94 49.12 47.83 47.86 45.60 15,325,308
Dec 4, 2025 47.98 48.24 47.37 47.99 45.73 18,457,125
Dec 3, 2025 47.63 48.11 47.30 47.57 45.33 11,472,469
Dec 2, 2025 47.86 47.98 47.37 47.43 45.19 11,905,167
Dec 1, 2025 48.92 49.49 48.37 48.43 46.15 11,626,707
Nov 28, 2025 49.13 49.70 48.35 49.35 47.02 15,484,203
Nov 26, 2025 48.53 49.03 48.18 48.71 46.41 17,834,795
Nov 25, 2025 45.98 47.21 45.94 47.06 44.84 30,458,571
Nov 24, 2025 43.42 45.22 43.08 44.97 42.85 73,618,723
Nov 21, 2025 47.02 48.15 46.69 47.63 45.38 18,985,250
Nov 20, 2025 49.50 49.53 47.48 47.60 45.35 15,252,292
Nov 19, 2025 48.03 49.38 47.76 49.00 46.69 16,585,034

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Novo-Nordisk A/S Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at NVO, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation